Home / Private raises / Gossamer Bio, Inc.

Gossamer Bio, Inc.

Biotechnology · San Diego, California · $25.0M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-09-04D (new)$25.0M$150M38506(b)Options/warrants, Security to be acquiredAug 20SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Sold through (placement agents)

Sales commissions $1.4M in the latest filing.

Issuer

IndustryBiotechnology
LocatedSan Diego, California
EntityCorporation
IncorporatedDelaware
SEC CIK1728117

People named in the latest filing

NameRole
Faheem HasnainExecutive Officer, Director
Russell CoxDirector
Thomas DanielDirector
Skye J. DrynanDirector
Sandra MilliganDirector
Steven D. NathanDirector
John QuiselDirector
Bryan GiraudoExecutive Officer
Christian WaageExecutive Officer
Robert SmithExecutive Officer
Caryn PetersonExecutive Officer

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?